Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020
Research

Tick-Borne Encephalitis Virus, United Kingdom

Maya HoldingComments to Author , Stuart D. Dowall, Jolyon M. Medlock, Daniel P. Carter, Steven T. Pullan, James Lewis, Richard Vipond, Mara S. Rocchi, Matthew Baylis, and Roger Hewson
Author affiliations: National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK (M. Holding, S.D. Dowall, J.M. Medlock, D.P. Carter, R. Vipond, M.S. Rocchi, M. Baylis, R. Hewson); Virology and Pathogenesis Group, National Infection Service, Public Health England, Porton Down, UK (M. Holding, S.D. Dowall, R. Vipond, R. Hewson); Medical Entomology and Zoonoses Ecology, Emergency Response Department, Public Health England, Porton Down (M. Holding, J.M. Medlock); Genomics, National Infection Service, Public Health England, Porton Down (D.P. Carter, S.T. Pullan); Geographic Information Systems, Emergency Response Department, Public Health England, Porton Down (J. Lewis); Virus Surveillance Unit, Moredun Research Institute, Edinburgh, Scotland, UK (M.S. Rocchi); Institute of Infection and Global Health, University of Liverpool, Liverpool (M. Baylis)

Main Article

Table 2

ELISA- and HAI-positive results for tick-borne encephalitis virus from counties from which serum samples were submitted, United Kingdom*

County and country ELISA
 HAI
No. positive/no. tested % Positive (95% CI)† No. positive/no. tested % Positive (95% CI)†
Norfolk, England 18/35 51.43 (35.57–67.01) 16/35 45.71 (30.46–61.82)
Hampshire, England 15/105 14.29 (8.74–22.35) 14/104 13.46 (8.07–21.46)
Suffolk, England 3/28 10.71 (2.90–28.01) 2/28 7.14 (0.90–23.73)
Highland, Scotland 7/81 8.64 (3.99–17.04) 8/81 9.88 (4.86–18.53)
Perth and Kinross, Scotland 2/33 6.06 (0.68–20.60) 10/33 30.30 (17.25–47.46)
Dorset, England 2/72 2.78 (0.19–10.15) 0/70 0.00 (0.00–6.23)
Cumbria, England 2/95 2.11 (0.12–7.81) 4/95 4.21 (1.31–10.67)
Argyll and Bute, Scotland 3/158 1.90 (0.40–5.69) 5/158 3.16 (1.16–7.39)
Wiltshire, England 1/56 1.79 (0.00–10.34) 5/55 9.09 (3.53–19.99)
Stirling, Scotland 0/2 0.00 (0.00–70.98) 1/2 50.00 (9.45–90.55)
Somerset, England 0/13 0.00 (0.00–26.59) 1/13 7.69 (0.00–35.42)
Moray, Scotland 0/19 0.00 (0.00–19.79) 1/19 5.26 (0.00–26.48)
Gloucestershire, England 0/24 0.00 (0.0016.31) 1/24 4.17 (0.00–21.87)
Aberdeenshire, Scotland 0/32 0.00 (0.00–12.73) 1/32 3.13 (0.00–17.11)

*HAI, hemagglutination inhibition.
†95% CIs computed by Agresti Coull method.

Main Article

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external